• Je něco špatně v tomto záznamu ?

A novel model for in vivo quantification of immediate liver perfusion impairment after pancreatic islet transplantation

L. Kosinova, A. Patikova, D. Jirak, A. Galisova, A. Vojtiskova, F. Saudek, J. Kriz,

. 2019 ; 11 (6) : 129-140. [pub] 20190909

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20022942

Grantová podpora
NV16-28254A MZ0 CEP - Centrální evidence projektů
NV16-28254A MZ0 CEP - Centrální evidence projektů

Instant Blood-Mediated Inflammatory Reaction (IBMIR) is a major cause of graft loss during pancreatic islet transplantation, leading to a low efficiency of this treatment method and significantly limiting its broader clinical use. Within the procedure, transplanted islets obstruct intrahepatic portal vein branches and consequently restrict blood supply of downstream lying liver tissue, resulting typically in ischemic necrosis. The extent of ischemic lesions is influenced by mechanical obstruction and inflammation, as well as subsequent recanalization and regeneration capacity of recipient liver tissue. Monitoring of immediate liver perfusion impairment, which is directly related to the intensity of post-transplant inflammation and thrombosis (IBMIR), is essential for improving therapeutic and preventive strategies to improve overall islet graft survival. In this study, we present a new experimental model enabling direct quantification of liver perfusion impairment after pancreatic islet transplantation using ligation of hepatic arteries followed by contrast-enhanced magnetic resonance imaging (MRI). The ligation of hepatic arteries prevents the contrast agent from circumventing the portal vein obstruction and enables to discriminate between well-perfused and non-perfused liver tissue. Here we demonstrate that the extent of liver ischemia reliably reflects the number of transplanted islets. This model represents a useful tool for in vivo monitoring of biological effect of IBMIR-alleviating interventions as well as other experiments related to liver ischemia. This technical paper introduces a novel technique and its first application in experimental animals.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20022942
003      
CZ-PrNML
005      
20220329145452.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1080/19382014.2019.1651164 $2 doi
035    __
$a (PubMed)31498024
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kosinova, Lucie $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. First Faculty of Medicine, Charles University, Prague, Czech Republic.
245    12
$a A novel model for in vivo quantification of immediate liver perfusion impairment after pancreatic islet transplantation / $c L. Kosinova, A. Patikova, D. Jirak, A. Galisova, A. Vojtiskova, F. Saudek, J. Kriz,
520    9_
$a Instant Blood-Mediated Inflammatory Reaction (IBMIR) is a major cause of graft loss during pancreatic islet transplantation, leading to a low efficiency of this treatment method and significantly limiting its broader clinical use. Within the procedure, transplanted islets obstruct intrahepatic portal vein branches and consequently restrict blood supply of downstream lying liver tissue, resulting typically in ischemic necrosis. The extent of ischemic lesions is influenced by mechanical obstruction and inflammation, as well as subsequent recanalization and regeneration capacity of recipient liver tissue. Monitoring of immediate liver perfusion impairment, which is directly related to the intensity of post-transplant inflammation and thrombosis (IBMIR), is essential for improving therapeutic and preventive strategies to improve overall islet graft survival. In this study, we present a new experimental model enabling direct quantification of liver perfusion impairment after pancreatic islet transplantation using ligation of hepatic arteries followed by contrast-enhanced magnetic resonance imaging (MRI). The ligation of hepatic arteries prevents the contrast agent from circumventing the portal vein obstruction and enables to discriminate between well-perfused and non-perfused liver tissue. Here we demonstrate that the extent of liver ischemia reliably reflects the number of transplanted islets. This model represents a useful tool for in vivo monitoring of biological effect of IBMIR-alleviating interventions as well as other experiments related to liver ischemia. This technical paper introduces a novel technique and its first application in experimental animals.
650    _2
$a zvířata $7 D000818
650    12
$a embolie $x komplikace $x diagnóza $7 D004617
650    _2
$a přežívání štěpu $7 D006085
650    _2
$a vylepšení obrazu $x metody $7 D007089
650    12
$a ischemie $x diagnostické zobrazování $x etiologie $7 D007511
650    _2
$a transplantace Langerhansových ostrůvků $x škodlivé účinky $7 D016381
650    12
$a játra $x krevní zásobení $x diagnostické zobrazování $x patologie $7 D008099
650    _2
$a magnetická rezonanční angiografie $x metody $7 D018810
650    _2
$a teoretické modely $7 D008962
650    12
$a vena portae $7 D011169
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a reprodukovatelnost výsledků $7 D015203
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pátíková, Alžběta, $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. First Faculty of Medicine, Charles University, Prague, Czech Republic. $d 1990- $7 xx0271325
700    1_
$a Jirak, Daniel $u Magnetic Resonance Unit, Radiodiagnostic and Interventional Radiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Institute of Biophysics and Informatics, Charles University, Prague, Czech Republic.
700    1_
$a Galisova, Andrea $u Magnetic Resonance Unit, Radiodiagnostic and Interventional Radiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Vojtiskova, Alzbeta $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Saudek, Frantisek $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Kriz, Jan $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
773    0_
$w MED00205664 $t Islets $x 1938-2022 $g Roč. 11, č. 6 (2019), s. 129-140
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31498024 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20220329145448 $b ABA008
999    __
$a ok $b bmc $g 1595261 $s 1113618
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 11 $c 6 $d 129-140 $e 20190909 $i 1938-2022 $m Islets $n Islets $x MED00205664
GRA    __
$a NV16-28249A $a NV16-28254A $p MZ0 $p MZ0
GRA    __
$a NV16-28249A $a NV16-28254A $p MZ0 $p MZ0
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace